06:58 AM EST, 11/21/2024 (MT Newswires) -- Novartis AG ( NVS ) said Thursday that it is upgrading its mid-term sales growth guidance to 6% for 2023 to 2028, compared with 5% previously.
The company expects to grow sales by 5% from 2024 to 2029, rolling forward its mid-term guidance with 2024 as the base year.